A new study finds that the U.S. pays up to 4.1 times more for branded drugs than in other countries and that if Medicare Part D had used the same pricing as others the U.S. could have saved nearly $73 billion last year. httpsbuff.ly2PTVV04Â

A new study finds that the U.S. pays up to 4.1 times more for branded drugs than in other countries, and that if Medicare Part D had used the same pricing as others, the U.S. could have saved nearly $73 billion last year. https://buff.ly/2PTVV04 

A new study finds that the U.S. pays up to 4.1 times more for branded drugs than in other countries, and that if Medicare Part D had used the same pricing as others, the U.S. could have saved nearly $73 billion last year. https://buff.ly/2PTVV04 

More From BioPortfolio on "A new study finds that the U.S. pays up to 4.1 times more for branded drugs than in other countries, and that if Medicare Part D had used the same pricing as others, the U.S. could have saved nearly $73 billion last year. https://buff.ly/2PTVV04 "